INLB - Item 9 Labs Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
4.4800
-0.0200 (-0.44%)
At close: 1:37PM EDT
Stock chart is not supported by your current browser
Previous Close4.5000
Open4.5000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.4800 - 4.5000
52 Week Range0.1000 - 8.4000
Volume683
Avg. Volume2,009
Market Cap276.547M
Beta (3Y Monthly)1.52
PE Ratio (TTM)N/A
EPS (TTM)-1.1940
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire3 hours ago

    Item 9 Labs Corp. CEO Sara Gullickson Issues Welcome Letter to Shareholders

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today released the following welcome letter to Item 9 shareholders from Sara Gullickson, CEO. As we enter Q2, I am taking this opportunity to introduce myself as the new Chief Executive Officer of Item 9 Labs Corp. This appointment is the culmination of many personal goals, and a position where Item 9 Labs shareholders will benefit from the skills and expertise gained throughout my nine-year cannabis career. My entrepreneurial journey began by winning multiple medical marijuana licenses across more than a dozen state markets, as well as helping to develop regulatory frameworks in the United States, Canada, Europe, and New Zealand.

  • GlobeNewswire15 days ago

    Item 9 Labs Corp. Breaks Ground on Cannabis Cultivation and Processing Facility Strive Wellness of Nevada

    LAS VEGAS, April 08, 2019 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leading developer and manufacturer of innovative cannabis products and.

  • GlobeNewswire25 days ago

    Item 9 Labs Corp. Appoints Jeffrey Rassás as Executive Chairman of the Board

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced the appointment of Jeffrey Rassás as Executive Chairman of the Board of Directors. Rassás has resigned as Chief Strategic Officer of the Company to take on his new role as Executive Chairman.

  • GlobeNewswirelast month

    Item 9 Labs Woman CEO and Minority Board Members Awarded Processor Provisional License for Strive Wellness of Ohio

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced CEO Sara Gullickson and African-American Advisory Board Members Donald Burton and Larry K. Lemons were awarded a processor provisional license for Strive Wellness of Ohio, LLC. The entity qualified as a disadvantaged group due to its minority-led ownership team. Item 9 Labs is in the process of negotiating a partnership agreement with Strive Wellness of Ohio to fund the management of the operation and introduce the Company’s diverse product suites.

  • GlobeNewswirelast month

    Item 9 Labs Corp Nears Completion of Facility Expansion to More Than Double Cultivation Output Capacity

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced its Arizona expansion has neared completion. The 10,000 square-foot construction will more than double output capacity with increased cultivation manufacturing space and an infusion kitchen.

  • GlobeNewswire2 months ago

    Medical Marijuana Dispensary Strive Life North Dakota Enters Supply Agreement With Pure Dakota Manufacturing

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced that medical marijuana dispensary Strive Life North Dakota, a partner following the Company’s Strive Life business model and brand, has entered into a letter of intent agreement with Pure Dakota, LLC, a premier supplier and manufacturer of usable marijuana.

  • GlobeNewswire2 months ago

    Item 9 Labs Corp Receives Top Honors at Arizona’s ERRL Cup Awards for Second Consecutive Year

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced it received top honors at Arizona’s 2019 ERRL Cup Awards for the second consecutive year. The Company’s Candyland and Tres Leches cannabis flower strains were named 1st Place Sativa and 2nd Place Hybrid respectively. Candyland previously received 1st Place Sativa honors at the 2018 ERRL Cup and the Company’s Vanilla Bean strain was named 1st Place Indica.

  • GlobeNewswire3 months ago

    Item 9 Labs Corps One Of The Fastest Growing Cannabis Concentrate Brands In Arizona According To BDS Analytics

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced it was ranked one of the fastest growing Arizona concentrate brands, according to industry data researcher BDS Analytics platform GreenEdgeTM Retail Tracking. The recently released data report showed Item 9 Labs increased concentrate sales by 234 percent in Q4 compared to Q1 of calendar year 2018. Concentrates are the fastest growing segment of the cannabis industry according to BDS Analytics, second only to dried flower with retail sales projected to hit USD $8 billion by 2022.

  • GlobeNewswire3 months ago

    Item 9 Labs Corps Appoints Medical Cannabis Executives to Advisory Board

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, named Donald Burton and Larry K. Lemons as new Advisory Board members. Burton and Lemons will support national expansion efforts at Item 9 Labs, implementing their decades of combined experience in the pharmaceutical and medical cannabis industries.

  • GlobeNewswire3 months ago

    Item 9 Labs Strengthens Executive Team

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced Chris Wolven is joining the executive team as Chief Operating Officer. Wolven previously served as Brand Chef at Fox Restaurant Concepts, a culinary powerhouse renowned for its boutique brands and thoughtfully curated dining experiences.  The group has an impressive lineup of more than 50 restaurant locations throughout the nation.

  • GlobeNewswire3 months ago

    Item 9 Labs Corp Broadens National Footprint Announces Joint Venture With Strive Wellness of Nevada

    Arizona-based Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), today announced a joint venture with Strive Wellness of Nevada, LLC (Strive Wellness), to construct and manage the 20,000 square-foot medical marijuana cultivation and processing facility in Pahrump, Nevada. Strive Wellness was approved for a medical marijuana license in April and received its Special Use Permit (SUP) in December 2018. Strive Wellness is estimated to be producing legal medical marijuana products in the next nine months.

  • GlobeNewswire4 months ago

    Item 9 Labs Corp. CEO Sara Gullickson Recognized as Influential Cannabis Leader Named Among Women to Watch in 2019

    Sara Gullickson, CEO of Item 9 Labs Corp. (INLB), recently was selected by Marijuana Business Magazine for its Women to Watch in 2019 list. Gullickson was highlighted as an intrepid entrepreneur who established her own cannabis consulting firm Dispensary Permits at age 26. In her Women to Watch interview, Gullickson provided advice for those interested in entering the market, “Slow and steady wins the race.

  • GlobeNewswire4 months ago

    Item 9 Labs Corp Appoints Andrew Bowden to Board of Directors

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, recently announced the appointment of Andrew Bowden, co-founder and CEO of Bowden Investment Group, to its Board of Directors. The capital will support the planned geographic expansion of the Company in Arizona and Nevada as it advances its cannabis industry presence.

  • GlobeNewswire4 months ago

    Item 9 Labs Nears Completion of 10,000 Square-Foot Cultivation Facility for Next Phase of Broader Expansion Plan

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced the commencement of the second phase of its national expansion plan. The Company is further enhancing its Arizona cultivation and processing facility to include a commercial kitchen for infusion processes and expanded its site by an additional 10,000 square-feet. “The expansion is a natural evolution for Item 9 Labs as we continue to develop distinctive and organic cannabis solutions for wellbeing.

  • GlobeNewswire5 months ago

    Sara Gullickson Named First Woman CEO of a U.S. Publicly Traded Cannabis Company Item 9 Labs Corp.

    Award-winning international cannabis consultant Sara Gullickson was recently named CEO of Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms. The appointment is of historic significance, establishing Gullickson as the first woman CEO of a U.S. publicly traded cannabis company. Gullickson formerly served as CEO and Founder of Dispensary Permits, which was acquired by Item 9 Labs on November 26, 2018.

  • GlobeNewswire5 months ago

    Item 9 Labs Corp. Closes Acquisition of Arizona DP Consulting Assets and DispensaryPermits.com

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced that on November 26, 2018, through its wholly owned subsidiary AZ DP Holdings, LLC, a Nevada limited liability company, that it closed on an Asset Purchase Agreement (the “Agreement”) with Arizona DP Consulting, LLC (“Dispensary Permits”) and its owner and founder Sara Gullickson, an award-winning international cannabis consultant with licensing success in over a dozen markets. Pursuant to the Agreement, the Company acquired the assets of Dispensary Permits, a nationally recognized cannabis consulting company specializing in helping entrepreneurs and industry stakeholders obtain cannabis licenses and build successful businesses.

  • GlobeNewswire5 months ago

    Item 9 Labs Corp. Secures $7.7 million for Geographic Expansion Plans

    SCOTTSDALE, Ariz., Nov. 20, 2018 -- Item 9 Labs Corp. (OTC: INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and.